cvs health glp-1 receptor agonist weight management diabetes treatments Stopping GLP-1s: What We Know GLP-1 medications may help regulate

Nat Rev Endocrinol 8:728742 Pyke C, Heller RS, Kirk RK et al (2014) GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody

Data were pooled for glucagon-like peptide 1 (GLP-1) receptor agonists and dipeptidyl-peptidase 4 (DPP-4) inhibitors in comparison with their respective controls and expressed as exposure-adjusted incidence rates

19% after 16 hr, n=90)

Still, it raises concerns about side effects, especially facial volume loss (Ozempic Face), which is now becoming a common topic in aesthetic medicine

Sassoon DJ, Tune JD, Mather KJ, Noblet JN, Eagleson MA, Conteh AM, Sturek JT, Goodwill AG

Cytokines mediated inflammation and decreased neurogenesis in animal models of depression